Fibrinogen concentrate (human)

🧮 Dose calculator

Congenital fibrinogen deficiency · Regimen source: FDA RiaSTAP · 2.1

• • Known level: dose (mg/kg) = (target − measured, mg/dL) ÷ 1.7. Target 100 mg/dL until haemostasis. Rate max 5 mL/min. FDA RiaSTAP · 2FDA RiaSTAP · 2.3

Enter age and weight.

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA RiaSTAP · 8.1

  “Risk Summary There are no studies of RIASTAP use in pregnant women.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA RiaSTAP · 8.2

  “Risk Summary There is no information regarding the presence of RIASTAP in human milk, its effects on the breastfed infant, or its effects on milk production.”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA RiaSTAP · 8.4

  “RIASTAP studies have included subjects below the age of 16 years.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA RiaSTAP · 8.5

  “The safety and efficacy of RIASTAP in the geriatric population has not been studied.”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.